British Health Minister Wes Streeting emphasized the pressing issue of obesity, stating that it's a significant burden on the NHS, costing £11 billion annually, even surpassing smoking.
Streeting elaborated on the monumental impact that weight loss drugs could have in addressing obesity, indicating their potential in improving health outcomes and easing healthcare pressures.
Prime Minister Keir Starmer highlighted the economic implications of weight loss drugs, asserting their significance in helping people return to work and the necessity for innovative funding solutions for the NHS.
Eli Lilly's new $365 million investment will fund a trial of their obesity drug Mounjaro involving 3,000 patients over five years, reflecting the UK's proactive stance on tackling obesity.
Collection
[
|
...
]